-
1
-
-
0025918727
-
No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin
-
Andersen BB, Mikkelsen M, Vesterager A, et al. No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Res 1991; 10: 201–204.
-
(1991)
Epilepsy Res
, vol.10
, pp. 201-204
-
-
Andersen, B.B.1
Mikkelsen, M.2
Vesterager, A.3
-
2
-
-
0022577184
-
Does carbamazepine reduction in haloperidol plasma levels worsen psychotic symptoms?
-
Arana GW, Goff DC, Friedman H, et al. Does carbamazepine reduction in haloperidol plasma levels worsen psychotic symptoms? Am J Psychiatry 1986; 143: 650–651.
-
(1986)
Am J Psychiatry
, vol.143
, pp. 650-651
-
-
Arana, G.W.1
Goff, D.C.2
Friedman, H.3
-
3
-
-
0030050967
-
Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on chiral column application to pharmacokinetics
-
Ascalone V, Ripamonti M, Malavasi B. Stereospecific determination of amisulpride, a new benzamide derivative, in human plasma and urine by automated solid-phase extraction and liquid chromatography on chiral column application to pharmacokinetics. J Chromatogr B Biomed Appl 1986; 676: 95–105.
-
(1986)
J Chromatogr B Biomed Appl
, vol.676
, pp. 95-105
-
-
Ascalone, V.1
Ripamonti, M.2
Malavasi, B.3
-
4
-
-
0030030330
-
Concentrations and effects of oral midazolam are greatly reduced in patients on carbamazepine or phenytoin
-
Backman TJ, Olkkola KT, Ojala M, et al. Concentrations and effects of oral midazolam are greatly reduced in patients on carbamazepine or phenytoin. Epilepsia 1996; 37: 253–257.
-
(1996)
Epilepsia
, vol.37
, pp. 253-257
-
-
Backman, T.J.1
Olkkola, K.T.2
Ojala, M.3
-
5
-
-
0033957228
-
Clonazepam and sertraline: Absence of drug interaction in a multiple-dose study
-
Bonate PL, Kroboth PD, Smith RB, et al. Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. J Clin Psychopharmacol 2000; 20: 19–27.
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 19-27
-
-
Bonate, P.L.1
Kroboth, P.D.2
Smith, R.B.3
-
6
-
-
0032776927
-
A pilot study on risperidone metabolism: The role of cytochrome p450 2d6 and 3a
-
Bork JA, Rogers T, Wedlund PJ, et al. A pilot study on risperidone metabolism: the role of Cytochrome P450 2D6 and 3A. J Clin Psychiatry 1999; 60: 469–476.
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 469-476
-
-
Bork, J.A.1
Rogers, T.2
Wedlund, P.J.3
-
7
-
-
0028798939
-
A double blind comparison of ore 3770, amitriptyline and placebo in major depression
-
Bremner JD. A double blind comparison of ORE 3770, amitriptyline and placebo in major depression. J Clin Psychiatry 1995; 56: 519–526.
-
(1995)
J Clin Psychiatry
, vol.56
, pp. 519-526
-
-
Bremner, J.D.1
-
8
-
-
0031819040
-
The clinical effectiveness of venlafaxine in the treatment of depression
-
Burnett FE, Dinan TG. The clinical effectiveness of venlafaxine in the treatment of depression. Rev Contemp Pharmacol 1994; 9: 303–320.
-
(1994)
Rev Contemp Pharmacol
, vol.9
, pp. 303-320
-
-
Burnett, F.E.1
Dinan, T.G.2
-
9
-
-
0028052932
-
Serum concentrations of clozapine and its major metabolites: Effects of cotreatment with fluoxetine or valproate
-
Centorrino F, Baldessarini RJ, Kando J, et al. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. Am J Psychiatry 1994; 151: 123–125.
-
(1994)
Am J Psychiatry
, vol.151
, pp. 123-125
-
-
Centorrino, F.1
Baldessarini, R.J.2
Kando, J.3
-
10
-
-
0033813124
-
The effects of lamotrigine on the pharmacokinetics of lithium
-
Chen C, Veronese L, Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacol 2000; 50: 193–195.
-
(2000)
Br J Clin Pharmacol
, vol.50
, pp. 193-195
-
-
Chen, C.1
Veronese, L.2
Yin, Y.3
-
11
-
-
0031889131
-
Ethnicity and clozapine metabolism
-
Chong SA, Remington G. Ethnicity and clozapine metabolism. Br J Psychiatry 1998; 172: 97 [Letter].
-
(1998)
Br J Psychiatry
, vol.172
, pp. 97
-
-
Chong, S.A.1
Remington, G.2
-
12
-
-
0028906843
-
A clinically significant interaction between clozapine and valproate
-
Costello LE, Suppes T. A clinically significant interaction between clozapine and valproate. J Clin Psychopharmacol 1995; 15: 139–141.
-
(1995)
J Clin Psychopharmacol
, vol.15
, pp. 139-141
-
-
Costello, L.E.1
Suppes, T.2
-
13
-
-
0029793726
-
Amisulpride: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia
-
Coukell AJ, Spencer CM, Benfield P. Amisulpride: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia. CNS Drugs 1996; 6: 237–256.
-
(1996)
CNS Drugs
, vol.6
, pp. 237-256
-
-
Coukell, A.J.1
Spencer, C.M.2
Benfield, P.3
-
15
-
-
0019819007
-
Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration
-
Dhillon S, Richens A. Pharmacokinetics of diazepam in epileptic patients and normal volunteers following intravenous administration. Br J Clin Pharmacol 1981; 12: 841–844.
-
(1981)
Br J Clin Pharmacol
, vol.12
, pp. 841-844
-
-
Dhillon, S.1
Richens, A.2
-
16
-
-
0000230135
-
No clinically significant effect of topiramate on haloperidol plasma concentration
-
Doose DR, Kohl KA, Desai-Krieger D, et al. No clinically significant effect of topiramate on haloperidol plasma concentration. Eur Neuropsychopharmacol 1999; 9: S357 [Abstract].
-
(1999)
Eur Neuropsychopharmacol
, vol.9
-
-
Doose, D.R.1
Kohl, K.A.2
Desai-Krieger, D.3
-
17
-
-
0022616703
-
A case of phenytoin toxicity possibly precipitated by trazodone
-
Dorn JM. A case of phenytoin toxicity possibly precipitated by trazodone. J Clin Psychiatry 1986; 47: 89–90.
-
(1986)
J Clin Psychiatry
, vol.47
, pp. 89-90
-
-
Dorn, J.M.1
-
18
-
-
0027279882
-
Toxic serotonin syndrome after fluoxetine plus carbamazepine
-
Dursun SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet 1993; 342: 442–443.
-
(1993)
Lancet
, vol.342
, pp. 442-443
-
-
Dursun, S.M.1
Mathew, V.M.2
Reveley, M.A.3
-
19
-
-
0018103006
-
Beuthin fc. Phenobarbital–thioridazine interaction in man
-
Ellenor GL, Musa MN, Beuthin FC. Phenobarbital–thioridazine interaction in man. Res Commun Chem Pathol Pharmacol 1978; 21: 185–188.
-
(1978)
Res Commun Chem Pathol Pharmacol
, vol.21
, pp. 185-188
-
-
Ellenor, G.L.1
Musa, M.N.2
-
20
-
-
0029969184
-
Pharmacokinetics and drug interactions: Update for new antipsychotics
-
Ereshefsky L. Pharmacokinetics and drug interactions: update for new antipsychotics. J Clin Psychiatry 1996; 57(Suppl. 11): 12–25.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 12-25
-
-
Ereshefsky, L.1
-
21
-
-
0031725427
-
Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia
-
Facciola G, Avenoso A, Spina E, et al. Inducing effect of phenobarbital on clozapine metabolism in patients with chronic schizophrenia. Ther Drug Monit 1998; 20: 628–630.
-
(1998)
Ther Drug Monit
, vol.20
, pp. 628-630
-
-
Facciola, G.1
Avenoso, A.2
Spina, E.3
-
22
-
-
0033045133
-
Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders
-
Facciola G, Avenoso A, Scordo MG, et al. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit 1999; 21: 341–345.
-
(1999)
Ther Drug Monit
, vol.21
, pp. 341-345
-
-
Facciola, G.1
Avenoso, A.2
Scordo, M.G.3
-
23
-
-
0033063442
-
Metabolism of risperidone to 9-hydroxy-risperidone by human cytochromes p450 2d6 and 3a4
-
Fang J, Bourin M, Becher GB. Metabolism of risperidone to 9-hydroxy-risperidone by human cytochromes P450 2D6 and 3A4. Naunyn Schniedeberg’s Arch Pharmacol 1999; 359: 147–151.
-
(1999)
Naunyn Schniedeberg’s Arch Pharmacol
, vol.359
, pp. 147-151
-
-
Fang, J.1
Bourin, M.2
Becher, G.B.3
-
24
-
-
0033941001
-
Increase in serum clomipramine concentrations caused by valproate
-
Fehr C, Grunder G, Hiemke C, et al. Increase in serum clomipramine concentrations caused by valproate. J Clin Psychopharmacol 2000; 20: 493–494.
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 493-494
-
-
Fehr, C.1
Grunder, G.2
Hiemke, C.3
-
25
-
-
0028146698
-
Potential impact of valproic acid therapy on clozapine disposition
-
Finley P, Warner D. Potential impact of valproic acid therapy on clozapine disposition. Biol Psychiatry 1994; 36: 487–488.
-
(1994)
Biol Psychiatry
, vol.36
, pp. 487-488
-
-
Finley, P.1
Warner, D.2
-
26
-
-
0031985493
-
Mood stabilizer combinations: A review of safety and efficacy
-
Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998; 155: 12–21.
-
(1998)
Am J Psychiatry
, vol.155
, pp. 12-21
-
-
Freeman, M.P.1
Stoll, A.L.2
-
27
-
-
0031935923
-
Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam
-
Furukori H, Otani K, Yasui N, et al. Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam. Neuropsychopharmacology 1998; 18: 364–369.
-
(1998)
Neuropsychopharmacology
, vol.18
, pp. 364-369
-
-
Furukori, H.1
Otani, K.2
Yasui, N.3
-
28
-
-
0034829228
-
Different enantioselective 9-hydroxylation of risperidone by the two human cyp2d6 and cyp3a4 enzymes
-
Furukory NY, Hidestrand M, Spina E, et al. Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes. Drug Metab Dispos 2001; 29: 1263–1268.
-
(2001)
Drug Metab Dispos
, vol.29
, pp. 1263-1268
-
-
Furukory, N.Y.1
Hidestrand, M.2
Spina, E.3
-
29
-
-
0021015512
-
Interaction between phenobarbital and thioridazine
-
Gay PE, Madsen JA. Interaction between phenobarbital and thioridazine. Neurology 1983; 33: 1631–1632.
-
(1983)
Neurology
, vol.33
, pp. 1631-1632
-
-
Gay, P.E.1
Madsen, J.A.2
-
30
-
-
0025942772
-
Fluoxetine and parkinsonism in patients taking carbamazepine
-
Gernaat HB, Van de Woude J, Touw DJ. Fluoxetine and parkinsonism in patients taking carbamazepine. Am J Psychiatry 1991; 148: 1604–1605.
-
(1991)
Am J Psychiatry
, vol.148
, pp. 1604-1605
-
-
Gernaat, H.B.1
Van De Woude, J.2
Touw, D.J.3
-
31
-
-
0031706608
-
Glucuronidation of amine substrates by purified and expressed udpglucuronosyltransferase proteins
-
Green MD, Tephly TR. Glucuronidation of amine substrates by purified and expressed UDPglucuronosyltransferase proteins. Drug Metab Dispos 1998; 26: 860–867.
-
(1998)
Drug Metab Dispos
, vol.26
, pp. 860-867
-
-
Green, M.D.1
Tephly, T.R.2
-
32
-
-
0025788860
-
Increased carbamazepine plasma concentrations after fluoxetine coadministration
-
Grimsley SR, Jann MW, Carter JG, et al. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 1991; 50: 10–15.
-
(1991)
Clin Pharmacol Ther
, vol.50
, pp. 10-15
-
-
Grimsley, S.R.1
Jann, M.W.2
Carter, J.G.3
-
33
-
-
0030627336
-
Role of cytochrome p450 enzymes in drug–drug interactions
-
Guengerich FP. Role of cytochrome P450 enzymes in drug–drug interactions. Adv Pharmacol 1997; 43: 7–35.
-
(1997)
Adv Pharmacol
, vol.43
, pp. 7-35
-
-
Guengerich, F.P.1
-
34
-
-
7344255757
-
Safety and pharmacokinetics of a single dose of amisulpride in healthy elderly volunteers
-
Hamon-Vilcot B, Chaufour S, Deschamps JT, et al. Safety and pharmacokinetics of a single dose of amisulpride in healthy elderly volunteers. Eur J Clin Pharmacol 1998; 54: 405–409.
-
(1998)
Eur J Clin Pharmacol
, vol.54
, pp. 405-409
-
-
Hamon-Vilcot, B.1
Chaufour, S.2
Deschamps, J.T.3
-
35
-
-
0030887647
-
Elevated serum phenytoin concentrations associated with coadministration of sertraline
-
Haselberger MB, Freedman LS, Tolbert S. Elevated serum phenytoin concentrations associated with coadministration of sertraline. J Clin Psychopharmacol 1997; 17: 107–109.
-
(1997)
J Clin Psychopharmacol
, vol.17
, pp. 107-109
-
-
Haselberger, M.B.1
Freedman, L.S.2
Tolbert, S.3
-
36
-
-
0036191870
-
Relevance of new psychotropic drugs for the neurologist
-
Hensiek A, Trimble MR. Relevance of new psychotropic drugs for the neurologist. J Neurol Neurosurg Psychiatry 2002; 72: 281–285.
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.72
, pp. 281-285
-
-
Hensiek, A.1
Trimble, M.R.2
-
37
-
-
0032767148
-
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients
-
Hesslinger B, Normann C, Langosch JM, et al. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients. J Clin Psychopharmacol 1999; 19: 310–315.
-
(1999)
J Clin Psychopharmacol
, vol.19
, pp. 310-315
-
-
Hesslinger, B.1
Normann, C.2
Langosch, J.M.3
-
38
-
-
0032985593
-
Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: The analysis of therapeutic drug monitoring data
-
Hirokane G, Someya T, Takahashi S, et al. Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data. Ther Drug Monit 1999; 21: 82–86.
-
(1999)
Ther Drug Monit
, vol.21
, pp. 82-86
-
-
Hirokane, G.1
Someya, T.2
Takahashi, S.3
-
39
-
-
0029075854
-
The drug–drug interaction effects of haloperidol on plasma carbamazepine levels
-
Iwahashi K, Miyatake R, Suwaki H, et al. The drug–drug interaction effects of haloperidol on plasma carbamazepine levels. Clin Neuropharmacol 1995; 18: 233–236.
-
(1995)
Clin Neuropharmacol
, vol.18
, pp. 233-236
-
-
Iwahashi, K.1
Miyatake, R.2
Suwaki, H.3
-
41
-
-
0031970013
-
Lamotrigine toxicity secondary to sertraline
-
Kaufman KR, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure 1998; 7: 163–165.
-
(1998)
Seizure
, vol.7
, pp. 163-165
-
-
Kaufman, K.R.1
Gerner, R.2
-
42
-
-
0028877035
-
Addition of monoamine oxidase inhibitors to carbamazepine: Preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression
-
Ketter TA, Post RM, Parekh PI, et al. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression. J Clin Psychiatry 1995; 56: 471–475.
-
(1995)
J Clin Psychiatry
, vol.56
, pp. 471-475
-
-
Ketter, T.A.1
Post, R.M.2
Parekh, P.I.3
-
43
-
-
0022248718
-
Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia
-
Kidron R, Averbuch I, Klein E, et al. Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia. Biol Psychiatry 1985; 20: 219–222.
-
(1985)
Biol Psychiatry
, vol.20
, pp. 219-222
-
-
Kidron, R.1
Averbuch, I.2
Klein, E.3
-
44
-
-
0025327481
-
Addition of lithium carbonate to carbamazepine: Haematological and thyroid effects
-
Kramlinger KG, Post RM. Addition of lithium carbonate to carbamazepine: haematological and thyroid effects. Am J Psychiatry 1990; 147: 615–620.
-
(1990)
Am J Psychiatry
, vol.147
, pp. 615-620
-
-
Kramlinger, K.G.1
Post, R.M.2
-
45
-
-
0033392246
-
Pharmacokinetics of haloperidol: An update
-
Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clin Pharmacokinet 1999; 37: 435–456.
-
(1999)
Clin Pharmacokinet
, vol.37
, pp. 435-456
-
-
Kudo, S.1
Ishizaki, T.2
-
46
-
-
0021219203
-
Interactions between anticonvulsants and other commonly prescribed drugs
-
Kutt H. Interactions between anticonvulsants and other commonly prescribed drugs. Epilepsia 1984; 225(Suppl. 2): S118–S131.
-
(1984)
Epilepsia
, vol.225
, pp. S118-S131
-
-
Kutt, H.1
-
47
-
-
0018132387
-
Time-course of interaction between carbamazepine and clonazepam in normal man
-
Lai AA, Levy RH, Cutler RE. Time-course of interaction between carbamazepine and clonazepam in normal man. Clin Pharmacol Ther 1978; 24: 316–323.
-
(1978)
Clin Pharmacol Ther
, vol.24
, pp. 316-323
-
-
Lai, A.A.1
Levy, R.H.2
Cutler, R.E.3
-
50
-
-
0026719234
-
Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide (Ly201116)
-
Leander JD. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine and ameltolide (LY201116). Epilepsia 1992; 33: 573–576.
-
(1992)
Epilepsia
, vol.33
, pp. 573-576
-
-
Leander, J.D.1
-
51
-
-
0030018415
-
Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases
-
Leinonen E, Lepola U, Koponen H. Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases. Pharmacopsychiatry 1996; 29: 156–158.
-
(1996)
Pharmacopsychiatry
, vol.29
, pp. 156-158
-
-
Leinonen, E.1
Lepola, U.2
Koponen, H.3
-
52
-
-
0020565606
-
Analysis of parent drug-metabolite relationship in the presence of an inducer: Application to the carbamazepine–clobazam interaction in normal man
-
Levy RH, Lane EA, Guyot M, et al. Analysis of parent drug-metabolite relationship in the presence of an inducer: application to the carbamazepine–clobazam interaction in normal man. Drug Metab Dispos 1983; 11: 286–292.
-
(1983)
Drug Metab Dispos
, vol.11
, pp. 286-292
-
-
Levy, R.H.1
Lane, E.A.2
Guyot, M.3
-
53
-
-
0018897689
-
Effect of anticonvulsants in plasma haloperidol and thioridazine levels
-
Linnoila M, Viukari M, Vaisanen K, et al. Effect of anticonvulsants in plasma haloperidol and thioridazine levels. Am J Psychiatry 1980; 137: 829–921.
-
(1980)
Am J Psychiatry
, vol.137
, pp. 829-921
-
-
Linnoila, M.1
Viukari, M.2
Vaisanen, K.3
-
54
-
-
0028917675
-
Valproic acid effects on serum concentrations of clozapine and norclozapine
-
Longo LP, Salzman C. Valproic acid effects on serum concentrations of clozapine and norclozapine. Am J Psychiatry 1995; 152: 650.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 650
-
-
Longo, L.P.1
Salzman, C.2
-
55
-
-
0031770968
-
A pharmacokinetic interaction between carbamazepine and olanzapine: Observations on possible mechanism
-
Lucas RA, Gilfillan DJ, Bergstrom RF. A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism. Eur J Clin Pharmacol 1998; 54: 639–643.
-
(1998)
Eur J Clin Pharmacol
, vol.54
, pp. 639-643
-
-
Lucas, R.A.1
Gilfillan, D.J.2
Bergstrom, R.F.3
-
57
-
-
0035135648
-
Phenytoin intoxication induced by fluvoxamine
-
Mamiya K, Kojima K, Yukawa E, et al. Phenytoin intoxication induced by fluvoxamine. Ther Drug Monit 2001; 23: 75–77.
-
(2001)
Ther Drug Monit
, vol.23
, pp. 75-77
-
-
Mamiya, K.1
Kojima, K.2
Yukawa, E.3
-
58
-
-
0034015675
-
The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers
-
Miceli JJ, Anziano RJ, Robarge L, et al. The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers. Br J Clin Pharmacol 2000; 49(Suppl. 1): S65–S70.
-
(2000)
Br J Clin Pharmacol
, vol.49
, pp. S65-S70
-
-
Miceli, J.J.1
Anziano, R.J.2
Robarge, L.3
-
59
-
-
0032806449
-
Interaction between anticonvulsant and psychoactive drugs
-
Monaco F, Cicolin A. Interaction between anticonvulsant and psychoactive drugs. Epilepsia 1999; 40(Suppl. 10): S71–S76.
-
(1999)
Epilepsia
, vol.40
, pp. S71-S76
-
-
Monaco, F.1
Cicolin, A.2
-
60
-
-
0030785126
-
Reboxetine: Additional benefits to depressed patients
-
Montgomery SA. Reboxetine: additional benefits to depressed patients. J Psychopharmacol 1997; 11(Suppl.): S9–S15.
-
(1997)
J Psychopharmacol
, vol.11
, pp. SS9-S15
-
-
Montgomery, S.A.1
-
61
-
-
0036112837
-
Carbamazepine–risperidone interactions in patients with epilepsy
-
Mula M, Monaco F. Carbamazepine–risperidone interactions in patients with epilepsy. Clin Neuropharmacol 2002a; 25: 97–100.
-
(2002)
Clin Neuropharmacol
, vol.25
, pp. 97-100
-
-
Mula, M.1
Monaco, F.2
-
62
-
-
0036709357
-
Antiepileptic–antipsychotic drug interactions. A critical review of the evidence
-
(in press)
-
Mula M, Monaco F. Antiepileptic–antipsychotic drug interactions. A critical review of the evidence. Clin Neuropharmacol 2002b (in press).
-
(2002)
Clin Neuropharmacol
-
-
Mula, M.1
Monaco, F.2
-
63
-
-
0032160711
-
Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome p450 isoforms involved in the metabolism of iloperidone
-
Mutlib AE, Klein JT. Application of liquid chromatography/mass spectrometry in accelerating the identification of human liver cytochrome P450 isoforms involved in the metabolism of iloperidone. J Pharmacol Exp Ther 1998; 286: 1285–1293.
-
(1998)
J Pharmacol Exp Ther
, vol.286
, pp. 1285-1293
-
-
Mutlib, A.E.1
Klein, J.T.2
-
64
-
-
0019439210
-
Interactions of anticonvulsant drugs with mianserin and nomifensine
-
Nawishy S, Hathaway N, Turner P. Interactions of anticonvulsant drugs with mianserin and nomifensine. Lancet 1981; 2: 871–872.
-
(1981)
Lancet
, vol.2
, pp. 871-872
-
-
Nawishy, S.1
Hathaway, N.2
Turner, P.3
-
65
-
-
0035095338
-
Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors
-
Nelson MH, Birnbaum AK, Remmel RP. Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors. Epilepsy Res 2001; 44: 71–82.
-
(2001)
Epilepsy Res
, vol.44
, pp. 71-82
-
-
Nelson, M.H.1
Birnbaum, A.K.2
Remmel, R.P.3
-
66
-
-
0033674051
-
Effects of steady state bupropion on the pharmacokinetics of lamotrigine in healthy subjects
-
Odishaw J, Chen C. Effects of steady state bupropion on the pharmacokinetics of lamotrigine in healthy subjects. Pharmacotherapy 2000; 20: 1448–1453.
-
(2000)
Pharmacotherapy
, vol.20
, pp. 1448-1453
-
-
Odishaw, J.1
Chen, C.2
-
67
-
-
0035987335
-
Significant pharmacokinetic interaction between risperidone and carbamazepine: Its relationship with cyp2d6 genotypes
-
Ono S, Mihara K, Suzuki A, et al. Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes. Psychopharmacology (Berl) 2002; 162: 50–54.
-
(2002)
Psychopharmacology (Berl)
, vol.162
, pp. 50-54
-
-
Ono, S.1
Mihara, K.2
Suzuki, A.3
-
68
-
-
0028125185
-
Clozapine seizures: Experience with 5629 patients
-
Pacia SV, Devinsky O. Clozapine seizures: experience with 5629 patients. Neurology 1994; 44: 2247–2249.
-
(1994)
Neurology
, vol.44
, pp. 2247-2249
-
-
Pacia, S.V.1
Devinsky, O.2
-
71
-
-
0030002395
-
Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin
-
Rapeport WG, Muirhead DC, Williams SA, et al. Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoin. J Clin Psychiatry 1996a; 57(Suppl. 1): 24–28.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 24-28
-
-
Rapeport, W.G.1
Muirhead, D.C.2
Williams, S.A.3
-
72
-
-
0029918465
-
Absence of sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine
-
Rapeport WG, Williams SA, Muirhead DC, et al. Absence of sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine. J Clin Psychiatry 1996b; 57(Suppl. 1): 20–23.
-
(1996)
J Clin Psychiatry
, vol.57
, pp. 20-23
-
-
Rapeport, W.G.1
Williams, S.A.2
Muirhead, D.C.3
-
73
-
-
0030077735
-
Identification of the human cytochromes p450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine
-
Ring BJ, Catlow J, Lindsay TJ, et al. Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. J Pharmacol Exp Ther 1996; 276: 658–666.
-
(1996)
J Pharmacol Exp Ther
, vol.276
, pp. 658-666
-
-
Ring, B.J.1
Catlow, J.2
Lindsay, T.J.3
-
74
-
-
0034864619
-
Nefazodone may inhibit the metabolism of carbamazepine: Three case reports
-
Roth L, Bertschy G. Nefazodone may inhibit the metabolism of carbamazepine: three case reports. Eur Psychiatry 2001; 16: 320–321.
-
(2001)
Eur Psychiatry
, vol.16
, pp. 320-321
-
-
Roth, L.1
Bertschy, G.2
-
75
-
-
0021682578
-
Lithium–carbamazepine neurotoxicity and risk factors
-
Shukla S, Godwin CD, Long LEB, et al. Lithium–carbamazepine neurotoxicity and risk factors. Am J Psychiatry 1984; 141: 1604–1606.
-
(1984)
Am J Psychiatry
, vol.141
, pp. 1604-1606
-
-
Shukla, S.1
Godwin, C.D.2
Long, L.3
-
76
-
-
0027271955
-
Carbamazepine coadministration with fluoxetine or fluvoxamine
-
Spina E, Avenoso A, Pollicino AM, et al. Carbamazepine coadministration with fluoxetine or fluvoxamine. Ther Drug Monit 1993; 15: 247–250.
-
(1993)
Ther Drug Monit
, vol.15
, pp. 247-250
-
-
Spina, E.1
Avenoso, A.2
Pollicino, A.M.3
-
77
-
-
0033853419
-
Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate
-
Spina E, Avenoso A, Facciolà G, et al. Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate. Ther Drug Monit 2000; 22: 481–485.
-
(2000)
Ther Drug Monit
, vol.22
, pp. 481-485
-
-
Spina, E.1
Avenoso, A.2
Facciolà, G.3
-
78
-
-
0035118696
-
Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression
-
Szymura-Oleksiak J, Wyska E, et al. Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression. Psychopharmacology (Berl) 2001; 154: 38–42.
-
(2001)
Psychopharmacology (Berl)
, vol.154
, pp. 38-42
-
-
Szymura-Oleksiak, J.1
Wyska, E.2
-
79
-
-
0025609394
-
Phenytoin–bupropion interaction: Effect on plasma phenytoin concentration in the rat
-
Tekle A, al-Kamis KI. Phenytoin–bupropion interaction: effect on plasma phenytoin concentration in the rat. J Pharm Pharmacol 1990; 42: 799–801.
-
(1990)
J Pharm Pharmacol
, vol.42
, pp. 799-801
-
-
Tekle, A.1
Al-Kamis, K.I.2
-
80
-
-
0036124003
-
Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: Pharmacodynamic considerations
-
Torta R, Monaco F. Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations. Epilepsia 2002; 43(Suppl. 2): 8–13.
-
(2002)
Epilepsia
, vol.43
, pp. 8-13
-
-
Torta, R.1
Monaco, F.2
-
81
-
-
0028901669
-
Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepam
-
Toy SM, Lucki I, Peirgies AA, et al. Pharmacokinetic and pharmacodynamic evaluation of the potential drug interaction between venlafaxine and diazepam. J Clin Pharmacol 1995; 35: 410–419.
-
(1995)
J Clin Pharmacol
, vol.35
, pp. 410-419
-
-
Toy, S.M.1
Lucki, I.2
Peirgies, A.A.3
-
82
-
-
0017356645
-
Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms
-
Trimble M, Anlezark G, Meldrum B. Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms. Psychopharmacology 1977; 51: 159–164.
-
(1977)
Psychopharmacology
, vol.51
, pp. 159-164
-
-
Trimble, M.1
Anlezark, G.2
Meldrum, B.3
-
83
-
-
0028905671
-
Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: A quantitative microdialysis study
-
Van Belle K, Sarre S, Ebinger G, et al. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study. J Pharmacol Exp Ther 1995; 272: 1217–1222.
-
(1995)
J Pharmacol Exp Ther
, vol.272
, pp. 1217-1222
-
-
Van Belle, K.1
Sarre, S.2
Ebinger, G.3
-
84
-
-
0026096988
-
Combined treatment with lithium and carbamazepine
-
Vieweg V, Shutty M, Hundley P, et al. Combined treatment with lithium and carbamazepine. Am J Psychiatry 1991; 148: 398–399.
-
(1991)
Am J Psychiatry
, vol.148
, pp. 398-399
-
-
Vieweg, V.1
Shutty, M.2
Hundley, P.3
-
85
-
-
0018838977
-
Phenothiazine induced phenytoin intoxication
-
Vincent FM. Phenothiazine induced phenytoin intoxication. Ann Intern Med 1980; 93: 56–57.
-
(1980)
Ann Intern Med
, vol.93
, pp. 56-57
-
-
Vincent, F.M.1
-
86
-
-
0029757143
-
Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics
-
Wong SL, Cavanaugh J, Shi H, et al. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics. Clin Pharmacol Ther 1996; 60: 48–53.
-
(1996)
Clin Pharmacol Ther
, vol.60
, pp. 48-53
-
-
Wong, S.L.1
Cavanaugh, J.2
Shi, H.3
-
87
-
-
0035142323
-
The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine
-
Wong YW, Yeh C, Thyrum PT. The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine. J Clin Psychopharmacol 2001; 21: 89–93.
-
(2001)
J Clin Psychopharmacol
, vol.21
, pp. 89-93
-
-
Wong, Y.W.1
Yeh, C.2
Thyrum, P.T.3
-
88
-
-
0027957693
-
Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats
-
Yan QS, Jobe PC, Dailey JW. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol 1994; 252: 105–112.
-
(1994)
Eur J Pharmacol
, vol.252
, pp. 105-112
-
-
Yan, Q.S.1
Jobe, P.C.2
Dailey, J.W.3
|